Suchergebnisse - "Horváth, Gábor"

PubPharm (24)

1

Hepatitis C Screening and Treatment Program in Hungarian Prisons in the Era of Direct Acting Antiviral Agents

enthalten in: Viruses | 2022

von Werling, K. | Hunyady, B. | Makara, M. | +13

2

Randomized clinical trials towards a single-visit cure for chronic hepatitis C : Oral GSK2878175 and injectable RG-101 in chronic hepatitis C patients and long-acting injectable GSK2878175 in healthy participants

enthalten in: Journal of viral hepatitis | 2020

von Deng, Y. | Campbell, F. | Han, K. | +14

3

Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1-6 and compensated cirrhosis : The EXPEDITION-8 trial

enthalten in: Journal of hepatology | 2020

von Brown, R. | Buti, M. | Rodrigues, L. | +19

CommentIn: J Hepatol. 2020 Mar;72(3):389-390. - PMID 31703944

4

Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 22 September 2017

enthalten in: Orvosi hetilap | 2018

von Hunyady, B. | Gerlei, Z. | Gervain, J. | +10

5

Diagnosis and treatment of chronic hepatitis B and D. National consensus guideline in Hungary from 22 September 2017

enthalten in: Orvosi hetilap | 2018

von Horváth, G. | Gerlei, Z. | Gervain, J. | +8

6

Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030 : a modelling study

enthalten in: The lancet. Gastroenterology & hepatology | 2017

von European Union HCV Collaborators | Razavi, H. | Robbins, S. | +98

CommentIn: Lancet Gastroenterol Hepatol. 2017 May;2(5):313. - PMID 28397689

7

Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 15 October 2016

enthalten in: Orvosi hetilap | 2017

von Hunyady, B. | Gerlei, Z. | Gervain, J. | +10

8

Diagnosis and treatment of chronic hepatitis B and D. National consensus guideline in Hungary from 15 October 2016

enthalten in: Orvosi hetilap | 2017

von Horváth, G. | Gerlei, Z. | Gervain, J. | +8

9

Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin : A phase III randomized controlled trial

enthalten in: Journal of hepatology | 2016

von Sperl, J. | Horvath, G. | Halota, W. | +19

10

Randomised clinical trial : alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)

enthalten in: Alimentary pharmacology & therapeutics | 2015

von Zeuzem, S. | Flisiak, R. | Vierling, J. | +121